Viridian Therapeutics, Inc./DE
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $899.4M
Liabilities Breakdown FY2025
Total Liabilities: $177.3M
Asset Breakdown
Total Assets: $899.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $212.4M | 23.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.2M | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $685.8M | 76.3% |
Liabilities Breakdown
Total Liabilities: $177.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.7M | 4.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $168.6M | 95.1% |